Collaborating with the scientific capabilities, expertise and resources of TRND means moving promising small molecules and biologics into clinical testing. Successful applicants partner with TRND to develop and execute a milestone-driven drug development program. TRND provides drug development expertise and operations. The applicant collaborator(s) provide starting points for the project, ongoing biological/disease expertise, and when appropriate and with the support of TRND funding, efficacy or other testing of compounds developed in the course of the project. Detailed application instructions are available.
TRND is accepting applications from August 1 to September 30, 2012. To access the TRND solicitation, you must register or login to the proposalCENTRAL application system and click on Grant Opportunities.